Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 423

1.

Costs of bipolar disorder.

Kleinman L, Lowin A, Flood E, Gandhi G, Edgell E, Revicki D.

Pharmacoeconomics. 2003;21(9):601-22. Review.

PMID:
12807364
[PubMed - indexed for MEDLINE]
2.

Frequency of hospitalisations and inpatient care costs of manic episodes: in patients with bipolar I disorder in France.

de Zelicourt M, Dardennes R, Verdoux H, Gandhi G, Khoshnood B, Chomette E, Papatheodorou ML, Edgell ET, Even C, Fagnani F.

Pharmacoeconomics. 2003;21(15):1081-90.

PMID:
14596627
[PubMed - indexed for MEDLINE]
3.

The economic burden of depression in 1990.

Greenberg PE, Stiglin LE, Finkelstein SN, Berndt ER.

J Clin Psychiatry. 1993 Nov;54(11):405-18.

PMID:
8270583
[PubMed - indexed for MEDLINE]
4.

Cost of disorders of the brain in Europe 2010.

Gustavsson A, Svensson M, Jacobi F, Allgulander C, Alonso J, Beghi E, Dodel R, Ekman M, Faravelli C, Fratiglioni L, Gannon B, Jones DH, Jennum P, Jordanova A, Jönsson L, Karampampa K, Knapp M, Kobelt G, Kurth T, Lieb R, Linde M, Ljungcrantz C, Maercker A, Melin B, Moscarelli M, Musayev A, Norwood F, Preisig M, Pugliatti M, Rehm J, Salvador-Carulla L, Schlehofer B, Simon R, Steinhausen HC, Stovner LJ, Vallat JM, Van den Bergh P, van Os J, Vos P, Xu W, Wittchen HU, Jönsson B, Olesen J; CDBE2010Study Group.

Eur Neuropsychopharmacol. 2011 Oct;21(10):718-79. doi: 10.1016/j.euroneuro.2011.08.008. Epub 2011 Sep 15. Erratum in: Eur Neuropsychopharmacol. 2012 Mar;22(3):237-8. den Bergh, Peter Van [corrected to Van den Bergh, Peter].

PMID:
21924589
[PubMed - indexed for MEDLINE]
5.

[Bipolar I disorder in France: prevalence of manic episodes and hospitalisation-related costs].

de Zélicourt M, Dardennes R, Verdoux H, Gandhi G, Papatheodorou ML, Edgell ET, Khoshnood B, Chomette E, Even C, Fagnani F.

Encephale. 2003 May-Jun;29(3 Pt 1):248-53. Review. French.

PMID:
12876549
[PubMed - indexed for MEDLINE]
6.

Cost of depression in Europe.

Sobocki P, Jönsson B, Angst J, Rehnberg C.

J Ment Health Policy Econ. 2006 Jun;9(2):87-98.

PMID:
17007486
[PubMed - indexed for MEDLINE]
7.

The economic burden of affective disorders.

Rice DP, Miller LS.

Br J Psychiatry Suppl. 1995 Apr;(27):34-42.

PMID:
7794592
[PubMed - indexed for MEDLINE]
8.

The lifetime cost of bipolar disorder in the US: an estimate for new cases in 1998.

Begley CE, Annegers JF, Swann AC, Lewis C, Coan S, Schnapp WB, Bryant-Comstock L.

Pharmacoeconomics. 2001;19(5 Pt 1):483-95.

PMID:
11465308
[PubMed - indexed for MEDLINE]
9.

Costs associated with attempted suicide among individuals with bipolar disorder.

Stensland MD, Zhu B, Ascher-Svanum H, Ball DE.

J Ment Health Policy Econ. 2010 Jun;13(2):87-92.

PMID:
20919595
[PubMed - indexed for MEDLINE]
10.

The economic burden of bipolar disease.

Woods SW.

J Clin Psychiatry. 2000;61 Supp 13:38-41.

PMID:
11153811
[PubMed - indexed for MEDLINE]
11.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
[PubMed - indexed for MEDLINE]
12.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
[PubMed - indexed for MEDLINE]
13.

The economic burden of schizophrenia in the United States in 2002.

Wu EQ, Birnbaum HG, Shi L, Ball DE, Kessler RC, Moulis M, Aggarwal J.

J Clin Psychiatry. 2005 Sep;66(9):1122-9.

PMID:
16187769
[PubMed - indexed for MEDLINE]
14.

The societal costs and quality of life of patients suffering from bipolar disorder in the Netherlands.

Hakkaart-van Roijen L, Hoeijenbos MB, Regeer EJ, ten Have M, Nolen WA, Veraart CP, Rutten FF.

Acta Psychiatr Scand. 2004 Nov;110(5):383-92.

PMID:
15458562
[PubMed - indexed for MEDLINE]
15.

Annual cost of bipolar disorder to UK society.

Das Gupta R, Guest JF.

Br J Psychiatry. 2002 Mar;180:227-33.

PMID:
11872515
[PubMed - indexed for MEDLINE]
Free Article
16.

The annual impact of seasonal influenza in the US: measuring disease burden and costs.

Molinari NA, Ortega-Sanchez IR, Messonnier ML, Thompson WW, Wortley PM, Weintraub E, Bridges CB.

Vaccine. 2007 Jun 28;25(27):5086-96. Epub 2007 Apr 20.

PMID:
17544181
[PubMed - indexed for MEDLINE]
17.

Prevalence and humanistic impact of potential misdiagnosis of bipolar disorder among patients with major depressive disorder in a commercially insured population.

Kamat SA, Rajagopalan K, Pethick N, Willey V, Bullano M, Hassan M.

J Manag Care Pharm. 2008 Sep;14(7):631-42.

PMID:
18774873
[PubMed - indexed for MEDLINE]
Free Article
18.

Bipolar disorder: disease burden.

Sajatovic M.

Am J Manag Care. 2005 Jun;11(3 Suppl):S80-4. Review.

PMID:
16097718
[PubMed - indexed for MEDLINE]
Free Article
19.

Health and economic burden of metabolic comorbidity among individuals with bipolar disorder.

Centorrino F, Mark TL, Talamo A, Oh K, Chang J.

J Clin Psychopharmacol. 2009 Dec;29(6):595-600. doi: 10.1097/JCP.0b013e3181bef8a6.

PMID:
19910727
[PubMed - indexed for MEDLINE]
20.

Costs of attention deficit-hyperactivity disorder (ADHD) in the US: excess costs of persons with ADHD and their family members in 2000.

Birnbaum HG, Kessler RC, Lowe SW, Secnik K, Greenberg PE, Leong SA, Swensen AR.

Curr Med Res Opin. 2005 Feb;21(2):195-206.

PMID:
15801990
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk